Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study. [PDF]
PLoS Neglected Tropical DiseasesBackgroundPrimaquine (PQ) is the only widely available drug that eliminates latent hypnozoites, thereby preventing relapses of Plasmodium vivax malaria. Because PQ biotransformation mediated by the cytochrome P-450 (CYP) isoenzyme CYP2D6 is required for ...
Rodrigo M Corder +8 more
doaj +2 more sources
Costs Associated with Malaria in Pregnancy in the Brazilian Amazon, a Low Endemic Area Where Plasmodium vivax Predominates. [PDF]
, 2016 BACKGROUND: Information on costs associated with malaria in pregnancy (MiP) in low transmission areas where Plasmodium vivax predominates is so far missing. This study estimates health system and patient costs of MiP in the Brazilian Amazon.
Bardají, A +7 more
core +16 more sources
Village malaria workers for the community-based management of vivax malaria
The Lancet Regional Health - Southeast Asia, 2023 Summary: In Cambodia, malaria cases are on a trajectory towards the goal of malaria elimination by 2025. Vivax malaria is difficult to eliminate because of hypnozoites that can cause relapse.
Bipin Adhikari +6 more
doaj +1 more source
Vivax Malaria Presenting with Myelitis: A Rare Complication [PDF]
Journal of Clinical and Diagnostic Research, 2013 Neurological complications may occur with the Plasmodium falciparum infection. However, the association of neurological manifestations with vivax malaria remains doubtful. Of late, there are isolated case reports/studies which have implicated P.
Avijit Moulick +4 more
doaj +1 more source
Clinical impact of vivax malaria: A collection review.
PLoS Medicine, 2022 BackgroundPlasmodium vivax infects an estimated 7 million people every year. Previously, vivax malaria was perceived as a benign condition, particularly when compared to falciparum malaria.
Aung Pyae Phyo +3 more
doaj +1 more source
Rising report of Plasmodium vivax in sub-Saharan Africa: Implications for malaria elimination agenda
Scientific African, 2020 Plasmodium vivax and P. falciparum are the most important human malaria species. P. falciparum is considered the most virulent and widespread species in sub-Saharan Africa.
Mary Aigbiremo Oboh +5 more
doaj +1 more source
Insights into the elimination of vivax malaria in China
Infectious Diseases of Poverty, 2023 Background Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics.
Fang Huang, Li Zhang, Zhi-Gui Xia
doaj +1 more source
Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India
Annals of Clinical Microbiology and Antimicrobials, 2020 Background Plasmodium vivax, once considered benign species, is recently being recognised to be causing severe malaria like Plasmodium falciparum. In the present study, the authors report the trends in malaria severity in P.
Monika Matlani +4 more
doaj +1 more source
Severe vivax malaria in Eastern India
Asian Journal of Medical Sciences, 2015 Background: Conventionally, vivax malaria was called as benign malaria. But recent reports of severe vivax malaria were coming from different parts of the World.
Joydeep Mukherjee
doaj +1 more source
Frontiers in Medicine, 2023 IntroductionInfection with Plasmodium vivax is a recognized cause of severe malaria including deaths. The exact burden and patterns of severe P. vivax monoinfections is however still not well quantified, especially in P. vivax endemic regions.
Minh Cuong Duong +8 more
doaj +1 more source